These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38551099)

  • 81. Web-Based Risk Prediction Tool for an Individual's Risk of HIV and Sexually Transmitted Infections Using Machine Learning Algorithms: Development and External Validation Study.
    Xu X; Yu Z; Ge Z; Chow EPF; Bao Y; Ong JJ; Li W; Wu J; Fairley CK; Zhang L
    J Med Internet Res; 2022 Aug; 24(8):e37850. PubMed ID: 36006685
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Trajectories of PrEP use among men who have sex with men: a pooled analysis of two prospective, observational cohort studies.
    Jongen VW; Reyniers T; Schim van der Loeff M; Smekens T; Hoornenborg E; van den Elshout M; Zimmermann H; Coyer L; Kenyon C; De Baetselier I; Davidovich U; de Vries HJC; Prins M; Laga M; Vuylsteke B; Boyd A
    J Int AIDS Soc; 2023 Jul; 26(7):e26133. PubMed ID: 37501262
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Triple site sexually transmitted infection testing as a crucial component of surveillance for men who have sex with men: A prospective cohort study.
    Zucker R; Gaisa M; Sigel K; Singer I; Adler A; Turner D; Ben Ami R; Nissan I; Chan C; Halperin T
    Int J STD AIDS; 2022 Feb; 33(2):114-122. PubMed ID: 34676780
    [No Abstract]   [Full Text] [Related]  

  • 84. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System.
    Schmidt MA; Dickerson JF; O'Keeffe-Rosetti MC; Salas SB; Donald JL; Tao G
    Sex Transm Dis; 2022 Sep; 49(9):616-621. PubMed ID: 35724111
    [TBL] [Abstract][Full Text] [Related]  

  • 87. HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019.
    Koppe U; Seifried J; Marcus U; Albrecht S; Jansen K; Jessen H; Gunsenheimer-Bartmeyer B; Bremer V
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393929
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort.
    Secco AA; Akselrod H; Czeresnia J; Levy M; Byrne M; Monroe A; Lucar J; Horberg M; Castel AD; Doshi R; Rivasplata H; Squires L; Parenti D; Benator D;
    Sex Transm Infect; 2020 Mar; 96(2):89-95. PubMed ID: 31907326
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
    Cornelisse VJ; Fairley CK; Stoove M; Asselin J; Chow EPF; Price B; Roth NJ; Willcox J; Tee BK; Penn M; Chang CC; Armishaw J; Forgan-Smith G; Wright EJ;
    Clin Infect Dis; 2018 Nov; 67(12):1847-1852. PubMed ID: 29741665
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pilot implementation of a home-care programme with chlamydia, gonorrhoea, hepatitis B, and syphilis self-sampling in HIV-positive men who have sex with men.
    Leenen J; Hoebe CJPA; Ackens RP; Posthouwer D; van Loo IHM; Wolffs PFG; Dukers-Muijrers NHTM
    BMC Infect Dis; 2020 Dec; 20(1):925. PubMed ID: 33276727
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk factors for HIV and STI diagnosis in a community-based HIV/STI testing and counselling site for men having sex with men (MSM) in a large German city in 2011-2012.
    Marcus U; Ort J; Grenz M; Eckstein K; Wirtz K; Wille A
    BMC Infect Dis; 2015 Jan; 15():14. PubMed ID: 25582975
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Impact of Pre-exposure Prophylaxis for Human Immunodeficiency Virus on Gonorrhea Prevalence.
    Pharaon J; Bauch CT
    Bull Math Biol; 2020 Jul; 82(7):85. PubMed ID: 32613297
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Examining the Effects of PrEP Use on Sexual Behaviors and Sexually Transmitted Infections Among Chinese Men who have Sex with Men: A Cross-Sectional Study.
    She B; Lu F; Zhao R; Lin S; Sun J; He S; Liu Y; Su S; Zhang L
    AIDS Behav; 2024 Sep; 28(9):3128-3138. PubMed ID: 39066859
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis.
    Traeger MW; Schroeder SE; Wright EJ; Hellard ME; Cornelisse VJ; Doyle JS; Stoové MA
    Clin Infect Dis; 2018 Aug; 67(5):676-686. PubMed ID: 29509889
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prospective screening for monkeypox infection among users of HIV pre-exposure prophylaxis in Denmark.
    Thomassen SE; von Schreeb S; Kirkby NS; Pinholt M; Lebech AM; Kronborg G; Engsig FN
    Int J STD AIDS; 2024 Apr; 35(5):374-378. PubMed ID: 38164933
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Comparison of the burden of self-reported bacterial sexually transmitted infections among men having sex with men across 68 countries on four continents.
    Marcus U; Veras M; Casabona J; Caceres CF; Lachowsky N; Schink SB; Schmidt AJ
    BMC Public Health; 2023 May; 23(1):1008. PubMed ID: 37254096
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Assessing the Impact of HIV Preexposure Prophylaxis Scale-Up on Gonorrhea Incidence Among Gay and Bisexual Men in Sydney: A Mathematical Modeling Study.
    Walker ML; Stiasny D; Guy RJ; Law MG; Holt M; Mao L; Donovan B; Grulich AE; Gray RT; Regan DG
    Sex Transm Dis; 2022 Aug; 49(8):534-540. PubMed ID: 35608079
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antibacterial mouthwash to prevent sexually transmitted infections in men who have sex with men taking HIV pre-exposure prophylaxis (PReGo): a randomised, placebo-controlled, crossover trial.
    Van Dijck C; Tsoumanis A; Rotsaert A; Vuylsteke B; Van den Bossche D; Paeleman E; De Baetselier I; Brosius I; Laumen J; Buyze J; Wouters K; Lynen L; Van Esbroeck M; Herssens N; Abdellati S; Declercq S; Reyniers T; Van Herrewege Y; Florence E; Kenyon C
    Lancet Infect Dis; 2021 May; 21(5):657-667. PubMed ID: 33676596
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Factors Associated With Willingness to Use Daily Antibiotics as Sexually Transmitted Infection Prophylaxis Among HIV Preexposure Prophylaxis-Experienced Gay and Bisexual Men in Australia.
    Arapali T; Grulich AE; Heywood AE; Chan C; Fraser D; Zablotska IB; Holt M; Vaccher SJ; Bavinton BR
    Sex Transm Dis; 2023 Mar; 50(3):144-149. PubMed ID: 36730780
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Incidence of Hepatitis C Virus Infections Among Users of Human Immunodeficiency Virus Pre-exposure Prophylaxis.
    Tabatabavakili S; Aleyadeh W; Cerrocchi O; Janssen HLA; Hansen BE; Bogoch II; Feld JJ;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):674-681. PubMed ID: 33737225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.